MOLLY KERT: Open Payments
NPI 1124331665 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$395 in 6 payments from 5 companies in 2025. Trend: 2023 $889 · 2024 $662 · 2025 $395
Food & beverage: $375Education: $20
| Company | Payments | Amount |
|---|---|---|
| SCPHARMACEUTICALS INC. | 1 | $116 |
| E.R. Squibb & Sons, L.L.C. | 1 | $110 |
| Novo Nordisk Inc | 1 | $106 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $40 |
| Boston Scientific Corporation | 1 | $23 |
Products named: FUROSCIX, CAMZYOS, Ozempic, Kerendia, WATCHMAN FLX.
Industry payments across TX — which companies pay providers there.
